State Street Corp Ironwood Pharmaceuticals Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 13,917,111 shares of IRWD stock, worth $86.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,917,111
Previous 11,532,088
20.68%
Holding current value
$86.6 Million
Previous $132 Million
8.12%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$150 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$121 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$102 Million24.97% of portfolio
-
Pacer Advisors, Inc. Malvern, PA7.21MShares$44.8 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.1MShares$44.2 Million0.1% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $953M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...